{"id":32430,"date":"2025-06-11T17:52:42","date_gmt":"2025-06-11T12:22:42","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=32430"},"modified":"2025-10-09T17:33:59","modified_gmt":"2025-10-09T12:03:59","slug":"ai-healthcare-startups-funding-trends","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends","title":{"rendered":"AI Healthcare Startups: Unveiling Investment and Funding Trends"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a327c5d0c039\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a327c5d0c039\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Why_Investors_Are_All_In_on_AI_Healthcare\" >Why Investors Are All In on AI Healthcare<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Key_Drivers_Behind_the_Funding_Boom\" >Key Drivers Behind the Funding Boom<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Spotlight_on_New_AI_Pharma_and_MedTech_Startups\" >Spotlight on New AI Pharma and MedTech Startups<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Xaira_Therapeutics\" >Xaira Therapeutics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Intrepid_Labs\" >Intrepid Labs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Aeon\" >Aeon<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Kiin_Bio\" >Kiin Bio<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#OpenEvidence\" >OpenEvidence<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Axxam_and_Molecular_Health\" >Axxam and Molecular Health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Why_These_Startups_Matter\" >Why These Startups Matter<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Breakthrough_Applications_Fueling_Funding\" >Breakthrough Applications Fueling Funding<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Role_of_AI_in_Early_Detection_and_Precision_Treatment\" >Role of AI in Early Detection and Precision Treatment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#AIs_Transformative_Potential_in_Mental_Health_Diagnosis_and_Therapy\" >AI\u2019s Transformative Potential in Mental Health Diagnosis and Therapy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Why_Startups_Are_Investor_Catnip\" >Why Startups Are Investor Catnip<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Future_Outlook_and_Opportunities_for_Investors\" >Future Outlook and Opportunities for Investors<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Emerging_AI_Healthcare_Applications_Attracting_Venture_Capital\" >Emerging AI Healthcare Applications Attracting Venture Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Challenges_and_Risks_for_Investors_in_AI_Healthcare_Startups\" >Challenges and Risks for Investors in AI Healthcare Startups<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#Opportunities_Await_the_Bold\" >Opportunities Await the Bold<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n\n<p class=\"has-drop-cap\">Buckle up, because the world of AI healthcare startups is on fire! Investors are throwing serious cash, think billions, at companies using artificial intelligence to shake up the pharmaceutical industry. Over the past decade, a jaw-dropping <strong>USD 60 billion<\/strong> has flooded into AI healthcare startups, <strong>with USD 30 billion<\/strong> of that in just the last three years. In 2024 alone, these startups raked in <strong>USD 10.5 billion<\/strong> across <strong>511 deals<\/strong>, per <strong>PitchBook\u2019s data.<\/strong> That\u2019s not pocket change; it\u2019s a clear sign that AI is the golden ticket in healthcare innovation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-why-investors-are-all-in-on-ai-healthcare\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_All_In_on_AI_Healthcare\"><\/span>Why Investors Are All In on AI Healthcare<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>So, what\u2019s got investors so excited? It\u2019s simple: AI healthcare startups are solving big problems with even bigger potential. Take <strong>Xaira Therapeutics,<\/strong> which landed a whopping <strong>USD 1 billion <\/strong>Series A round in 2024, led by <strong>ARCH Venture Partners and Foresite Capital, <\/strong>to turbocharge drug discovery with AI. Then there\u2019s <strong>Hippocratic AI<\/strong>, grabbing <strong>USD 141 million<\/strong> in a Series B to bring generative AI to clinical tasks, and <strong>Insilico Medicine,<\/strong> securing <strong>USD 100 million <\/strong>in a Series E for AI-driven pharmaceutical R&amp;D. These aren\u2019t just big checks, they\u2019re votes of confidence in AI\u2019s power to transform healthcare.<\/p>\n\n\n\n<p>North America is a major hub for these investments, fueled by a robust biotech ecosystem and significant government support. For instance, the <strong>U.S. government invested USD 1.7 billion in 2021<\/strong> to advance genomic <strong>sequencing and AI-driven research<\/strong>, boosting pharmaceutical innovation. Asia Pacific is also racing ahead, with countries like China and India launching national AI strategies to support drug discovery. Startups like Exscientia are making waves, using platforms like Centaur Chemist to design a cancer drug that hit clinical trials in just 12 months\u2014way faster than traditional methods. Meanwhile, <strong>Tempus AI<\/strong>, valued at <strong>USD 11 billion<\/strong> post-IPO, and Verily, with <strong>USD 3.5 billion<\/strong> in funding, are pushing precision medicine forward.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-key-drivers-behind-the-funding-boom\"><span class=\"ez-toc-section\" id=\"Key_Drivers_Behind_the_Funding_Boom\"><\/span>Key Drivers Behind the Funding Boom<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Several factors are fueling this investment surge in AI healthcare startups:<\/p>\n\n\n\n<p><strong>Faster Drug Discovery<\/strong>: AI is slashing the time and cost of developing new drugs. Instead of 5-6 years, some startups are doing it in as little as one, like Exscientia. Generative AI is a game-changer here, designing brand-new molecules for tough diseases like cancer and Alzheimer\u2019s. Want a sneak peek at how this works? <a href=\"https:\/\/www.delveinsight.com\/report-store\/artificial-intelligence-ai-in-drug-discovery-market\">Click here to know<\/a> how AI crafts molecular structures to tackle major health challenges, predicting a market growth of 37.67% CAGR through 2032.&nbsp;<\/p>\n\n\n\n<p><strong>Personalized Medicine<\/strong>: Startups like GenomicDAO and ExactCure are using AI to create treatments tailored to your DNA, lifestyle, and health history. The <a href=\"https:\/\/www.delveinsight.com\/report-store\/ai-in-precision-medicine-market\">AI in Precision Medicine market<\/a>, valued at USD 1.04 billion in 2024, is projected to grow at a CAGR of 33.18%, reaching USD 10.24 billion by 2032. Investors love this kind of scalable, high-impact innovation.<\/p>\n\n\n\n<p><strong>Big Pharma Partnerships<\/strong>: The big dogs are teaming up with AI startups to boost their R&amp;D. Bayer\u2019s working with AI firms to speed up drug discovery for cancer and heart disease, while Pfizer\u2019s tapped IBM\u2019s Watson for R&amp;D efficiency. Mergers like Sanofi\u2019s acquisition of Amunix Pharmaceuticals show how AI is becoming a must-have for pharma giants.<\/p>\n\n\n\n<p><strong>Market Growth and Regulatory Wins<\/strong>: The global <a href=\"https:\/\/www.delveinsight.com\/report-store\/ai-in-diagnostics-market\">AI in Diagnostics market<\/a>, valued at USD 1.62 billion in 2024, is projected to grow at a CAGR of 22.31%, reaching USD 8.08 billion by 2032. North America\u2019s friendly regulations and approvals for AI-powered medical devices are giving investors the green light to keep pouring in cash.<\/p>\n\n\n\n<p>Sure, there are hurdles;<strong> clinical AI solutions need big bucks, and regulators are watching closely.<\/strong> But the potential is massive, especially in drug discovery. Our blog <a href=\"https:\/\/www.delveinsight.com\/blog\/generative-ai-drug-discovery-market-impact\"><em>Generative AI in Drug Discovery: Applications and Market Impact<\/em><\/a> shows how AI is turning the slow, costly process of drug development into a lean, mean innovation machine.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-spotlight-on-new-ai-pharma-and-medtech-startups\"><span class=\"ez-toc-section\" id=\"Spotlight_on_New_AI_Pharma_and_MedTech_Startups\"><\/span>Spotlight on New AI Pharma and MedTech Startups<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The AI healthcare revolution is in full swing, and a fresh wave of startups is leading the charge in pharmaceuticals and medical technology. These innovators are harnessing AI to tackle everything from drug discovery to preventive diagnostics, attracting serious investor attention. Here\u2019s a look at six exciting <strong>AI startups making headlines in 2025<\/strong>, each pushing the boundaries of what\u2019s possible in healthcare.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"257\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174255\/Top-AI-Healthcare-Startups-Driving-the-Next-Wave-of-Innovation-1024x257.png\" alt=\"Top-AI-Healthcare-Startups-Driving-the-Next-Wave-of-Innovation\" class=\"wp-image-32431\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174255\/Top-AI-Healthcare-Startups-Driving-the-Next-Wave-of-Innovation-1024x257.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174255\/Top-AI-Healthcare-Startups-Driving-the-Next-Wave-of-Innovation-300x75.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174255\/Top-AI-Healthcare-Startups-Driving-the-Next-Wave-of-Innovation-150x38.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174255\/Top-AI-Healthcare-Startups-Driving-the-Next-Wave-of-Innovation-768x193.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174255\/Top-AI-Healthcare-Startups-Driving-the-Next-Wave-of-Innovation-1536x385.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174255\/Top-AI-Healthcare-Startups-Driving-the-Next-Wave-of-Innovation-2048x514.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-xaira-therapeutics\"><span class=\"ez-toc-section\" id=\"Xaira_Therapeutics\"><\/span>Xaira Therapeutics<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Xaira Therapeutics is turning heads with its bold mission to accelerate drug discovery using AI. Launched in 2024, this San Francisco-based startup is building platforms that combine machine learning and computational biology to design new drugs faster than ever. Their USD 1 billion Series A round, led by ARCH Venture Partners and Foresite Capital, shows the massive confidence investors have in their vision. News. Xaira\u2019s tech aims to cut through the noise of traditional R&amp;D, pinpointing promising molecules for diseases like cancer and neurodegenerative disorders. It\u2019s no wonder they\u2019re a darling of the investment world, blending cutting-edge AI with real-world impact.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-intrepid-labs\"><span class=\"ez-toc-section\" id=\"Intrepid_Labs\"><\/span>Intrepid Labs<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Based in Toronto\u2019s MaRS Discovery District, Intrepid Labs is shaking up drug formulation with its Valiant platform\u2014a slick combination of AI and robotics that slashes formulation timelines from months to days. Founded in 2023, they\u2019ve already partnered with major pharmaceutical companies and contract research organizations to optimize drug development. Their tech lets researchers test multiple formulations at once, making drug development faster and cheaper. Intrepid is a perfect example of how AI is streamlining the less glamorous, but critical, parts of pharma, and investors are taking notice of its practical, scalable approach.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-aeon\"><span class=\"ez-toc-section\" id=\"Aeon\"><\/span>Aeon<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Swiss startup Aeon is redefining preventive healthcare with its AI-powered platform that catches diseases before symptoms even appear. By integrating full-body MRI scans, blood biomarkers, and genetic insights into a 60-minute check-up, Aeon delivers personalized health predictions. In 2025, they raised an \u20ac8.2 million seed round to scale their platform, with Swiss insurers covering up to 80% of costs, a game-changer for accessibility. Aeon\u2019s focus on early detection is winning over investors who see preventive medicine as the next big frontier in healthcare.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-kiin-bio\"><span class=\"ez-toc-section\" id=\"Kiin_Bio\"><\/span>Kiin Bio<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Across the pond in the UK, Kiin Bio is making waves in AI-driven drug discovery. This biotech startup secured pre-seed funding in 2025 to develop generative AI tools that design novel drug candidates. Their platform focuses on speeding up the early stages of drug development, helping researchers identify promising compounds for complex diseases. Kiin Bio\u2019s lean, tech-first approach is perfect for a fast-moving industry, and their early funding success signals strong investor belief in their potential to disrupt traditional pharma pipelines.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-openevidence\"><span class=\"ez-toc-section\" id=\"OpenEvidence\"><\/span>OpenEvidence<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>OpenEvidence, a Sequoia-backed AI medical assistant, is turning heads with its reported USD 100 million+ funding round at a USD 3 billion valuation in 2025, just months after a USD 75 million Series A. This startup is building AI tools to support clinicians with real-time, evidence-based insights, streamlining diagnostics and treatment planning. Their rapid valuation jump shows how hungry investors are for AI solutions that bridge the gap between data and clinical practice. OpenEvidence is poised to become a go-to for healthcare providers looking to make smarter, faster decisions.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-axxam-and-molecular-health\"><span class=\"ez-toc-section\" id=\"Axxam_and_Molecular_Health\"><\/span>Axxam and Molecular Health<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Axxam, an Italian biotech, teamed up with Molecular Health in 2025 to blend AI and biology for early-stage drug discovery. Their partnership focuses on using AI to analyze vast datasets and identify new therapeutic targets, speeding up the journey from lab to clinic. While not a traditional startup, this collaboration highlights how AI is driving innovation even among established players. Their work is attracting attention for its potential to unlock new treatments, making them a key player in the AI pharma investment boom.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-why-these-startups-matter\"><span class=\"ez-toc-section\" id=\"Why_These_Startups_Matter\"><\/span>Why These Startups Matter<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>These startups aren\u2019t just raising money, they\u2019re redefining healthcare. From Xaira\u2019s billion-dollar drug discovery platform to Aeon\u2019s preventive diagnostics, they\u2019re tackling the industry\u2019s toughest challenges with AI. Investors are betting big because these companies promise faster, cheaper, and more precise solutions.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-breakthrough-applications-fueling-funding\"><span class=\"ez-toc-section\" id=\"Breakthrough_Applications_Fueling_Funding\"><\/span>Breakthrough Applications Fueling Funding<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>AI healthcare startups are the rockstars of innovation, and investors can\u2019t get enough. By harnessing AI for early disease detection and mental health solutions, these companies are raking in billions while transforming lives. From pinpointing cancers to offering 24\/7 therapy, here\u2019s how startups in AI-driven diagnostics and mental health are driving the funding frenzy.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-role-of-ai-in-early-detection-and-precision-treatment\"><span class=\"ez-toc-section\" id=\"Role_of_AI_in_Early_Detection_and_Precision_Treatment\"><\/span>Role of AI in Early Detection and Precision Treatment<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Startups in <a href=\"https:\/\/www.delveinsight.com\/blog\/ai-driven-diagnostics-in-healthcare\">AI-driven diagnostics<\/a> are changing the game by catching diseases early and personalizing treatments, making them investor goldmines. Freenome, for instance, uses AI to detect colorectal cancer through simple blood tests, avoiding invasive procedures. They\u2019ve raised USD 1.35 billion total, including a USD 254 million round in February 2024 led by Roche, showing the massive trust in their multiomics platform.<\/p>\n\n\n\n<p>Paige AI is another heavy hitter, using AI to analyze pathology slides for faster, more accurate cancer diagnoses. They secured USD 125 million in a Series C round in January 2021, with additional funding in 2024 pushing their total to over USD 225 million, backed by investors like Goldman Sachs. PathAI, a Boston-based startup, is also making waves with AI-powered pathology tools, raising USD 255 million across five rounds, including a USD 165 million Series C in May 2021, led by General Catalyst.<\/p>\n\n\n\n<p>These startups are hot because they slash diagnostic times and improve outcomes, saving lives and healthcare costs.&nbsp;<\/p>\n\n\n\n<p><strong><em>If you are curious about AI\u2019s impact on cancer diagnostics, our blog <\/em><\/strong><a href=\"https:\/\/www.delveinsight.com\/blog\/role-of-ai-in-cancer-diagnostics\"><strong><em>AI in Cancer Diagnostics<\/em><\/strong><\/a><strong><em> dives into how startups like these are revolutionizing oncology.&nbsp;<\/em><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ai-s-transformative-potential-in-mental-health-diagnosis-and-therapy\"><span class=\"ez-toc-section\" id=\"AIs_Transformative_Potential_in_Mental_Health_Diagnosis_and_Therapy\"><\/span>AI\u2019s Transformative Potential in Mental Health Diagnosis and Therapy<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Mental health startups are using AI to make therapy accessible and effective, and investors are jumping on board. Wysa, a Boston-based startup, offers an AI chatbot delivering cognitive behavioral therapy (CBT) for anxiety and depression. They\u2019ve raised USD 30.5 million over nine rounds, including a USD 5.5 million Series A in May 2021 led by W Health Ventures and a USD 3.4 million NIH grant in 2024.<\/p>\n\n\n\n<p>Spring Health is soaring, using AI to match patients with personalized mental health plans. They raised USD 100 million in a Series E in September 2024, valuing them at USD 3.3 billion, with backing from Generation Investment Management. Kintsugi Health, based in Berkeley, detects depression through voice biomarkers, securing USD 20 million in a Series A in March 2022, led by Insight Partners.<\/p>\n\n\n\n<p>These startups are investor favorites because they offer scalable, 24\/7 solutions to a global mental health crisis. By analyzing speech or behavioral data, they catch issues early and deliver tailored care, driving both impact and profits.&nbsp;<\/p>\n\n\n\n<p><strong><em>Want to know more? Check out <\/em><\/strong><a href=\"https:\/\/www.delveinsight.com\/blog\/ai-in-mental-health-diagnosis-and-treatment#Happy_Healths_Smart_Ring_Receives_FDA_Clearance\"><strong><em>Exploring the Impact of AI in Mental Health<\/em><\/strong><\/a><strong><em> for a deeper dive into these game-changers.&nbsp;<\/em><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-why-startups-are-investor-catnip\"><span class=\"ez-toc-section\" id=\"Why_Startups_Are_Investor_Catnip\"><\/span>Why Startups Are Investor Catnip<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Startups like <strong>Freenome, Paige AI, PathAI, Wysa, Spring Health, and Kintsugi Health<\/strong> are pulling in massive funding because they\u2019re solving urgent healthcare challenges with AI. Their breakthroughs in early diagnostics and mental health care promise better outcomes and huge market potential, making them irresistible to investors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-future-outlook-and-opportunities-for-investors\"><span class=\"ez-toc-section\" id=\"Future_Outlook_and_Opportunities_for_Investors\"><\/span>Future Outlook and Opportunities for Investors<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The AI healthcare startup landscape is bursting with potential, and investors are racing to back the next big thing. From revolutionizing drug discovery to streamlining hospital workflows, these startups are drawing massive funding for their promise to transform healthcare. But it\u2019s not all smooth sailing\u2014navigating the risks is just as critical as spotting the opportunities. Here\u2019s a look at the emerging applications driving venture capital and the challenges investors need to keep in mind.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-emerging-ai-healthcare-applications-attracting-venture-capital\"><span class=\"ez-toc-section\" id=\"Emerging_AI_Healthcare_Applications_Attracting_Venture_Capital\"><\/span>Emerging AI Healthcare Applications Attracting Venture Capital<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>AI healthcare startups are shaking up the industry with innovations that tackle some of healthcare\u2019s toughest problems. Drug discovery is a hot spot, with companies using AI to design new molecules at lightning speed. Startups like Xaira Therapeutics, with its jaw-dropping billion-dollar funding round, are leading the charge by building platforms that slash years off traditional drug development timelines. Others, like Formation Bio, are also pulling in huge investments for their AI-driven approach to accelerating clinical trials, proving that pharma is ready to bet big on AI.<\/p>\n\n\n\n<p>Diagnostics is another area buzzing with activity. Startups are harnessing AI to spot diseases like cancer or Alzheimer\u2019s earlier than ever, offering hope for better outcomes. Companies like Aeon are making waves in preventive health, using AI to analyze scans and biomarkers for early warnings, catching the eye of investors who see the value in catching diseases before they spiral. Meanwhile, clinical workflow startups are easing the burden on doctors and nurses.&nbsp;<\/p>\n\n\n\n<p>Abridge, for example, uses generative AI to transcribe patient conversations, freeing up clinicians to focus on care rather than paperwork, a game-changer that\u2019s landed them significant funding. These applications aren\u2019t just innovative; they\u2019re practical, promising faster results, lower costs, and more personalized care.&nbsp;<\/p>\n\n\n\n<p><strong><em>For a deeper dive into what\u2019s fueling this excitement, check out <\/em><\/strong><a href=\"https:\/\/www.delveinsight.com\/blog\/top-applications-of-artificial-intelligence-in-healthcare\"><strong><em>Most Promising Artificial Intelligence Applications in the Healthcare Segment<\/em><\/strong><\/a><strong><em> to see the full scope of AI\u2019s impact.<\/em><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-challenges-and-risks-for-investors-in-ai-healthcare-startups\"><span class=\"ez-toc-section\" id=\"Challenges_and_Risks_for_Investors_in_AI_Healthcare_Startups\"><\/span>Challenges and Risks for Investors in AI Healthcare Startups<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Investing in AI healthcare startups is thrilling but comes with its share of obstacles. Regulatory hurdles top the list; getting FDA approval or meeting HIPAA standards can be a long, expensive slog. Startups need to prove their AI tools are safe and accurate, which often means burning through cash on clinical trials and validation studies. Data challenges are another pain point. AI thrives on clean, consistent data, but medical records are often messy and scattered, making it tough for startups like PathAI to deliver reliable results without significant effort.<\/p>\n\n\n\n<p>Then there\u2019s the risk of overhype. With so many startups claiming to be <strong><em>\u201cAI-powered,\u201d<\/em><\/strong> investors can struggle to separate the real innovators from those riding the buzzword wave. Many healthcare leaders are skeptical, favoring startups with proven results, which can make it harder for newer players to break through. These risks demand careful due diligence, but the potential payoffs, both in financial returns and societal impact, are hard to ignore.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-opportunities-await-the-bold\"><span class=\"ez-toc-section\" id=\"Opportunities_Await_the_Bold\"><\/span>Opportunities Await the Bold<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The future of AI healthcare startups is electric, with drug discovery, diagnostics, and clinical tools paving the way for a smarter, more efficient healthcare system. Companies that can navigate the regulatory maze and deliver reliable, impactful solutions are poised to dominate. Investors who back these trailblazers stand to gain not just profits but a stake in a healthier tomorrow.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/artificial-intelligence-ai-in-drug-discovery-market\"><img decoding=\"async\" width=\"1024\" height=\"194\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/02\/21220616\/ARTIFICIAL-INTELLIGENCE-IN-THE-PHARMA-SECTOR-1024x194.png\" alt=\"\" class=\"wp-image-32261\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/02\/21220616\/ARTIFICIAL-INTELLIGENCE-IN-THE-PHARMA-SECTOR-1024x194.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/02\/21220616\/ARTIFICIAL-INTELLIGENCE-IN-THE-PHARMA-SECTOR-300x57.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/02\/21220616\/ARTIFICIAL-INTELLIGENCE-IN-THE-PHARMA-SECTOR-150x28.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/02\/21220616\/ARTIFICIAL-INTELLIGENCE-IN-THE-PHARMA-SECTOR-768x145.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/02\/21220616\/ARTIFICIAL-INTELLIGENCE-IN-THE-PHARMA-SECTOR-1536x291.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/02\/21220616\/ARTIFICIAL-INTELLIGENCE-IN-THE-PHARMA-SECTOR.png 1584w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-faqs\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>FAQs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1760011408292\"><strong class=\"schema-faq-question\"><strong>What is the overall scale of funding into AI healthcare startups?<\/strong><\/strong> <p class=\"schema-faq-answer\">Over the past decade, AI healthcare startups have attracted about USD 60 billion in funding, with USD 30 billion of that raised in the last three years. In 2024 alone, these startups raised USD 10.5 billion across 511 deals.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1760011416073\"><strong class=\"schema-faq-question\"><strong>Which promising AI healthcare startups are making waves?<\/strong><\/strong> <p class=\"schema-faq-answer\">Several startups are making waves, including Xaira Therapeutics, Intrepid Labs, Aeon, Kiin Bio, OpenEvidence, Axxam &amp; Molecular Health, and others.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1760011427004\"><strong class=\"schema-faq-question\"><strong>What are the primary applications driving investment in AI healthcare startups?<\/strong><\/strong> <p class=\"schema-faq-answer\">Key areas attracting investment include Drug Discovery, Diagnostics, Clinical Decision Support, and others.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Buckle up, because the world of AI healthcare startups is on fire! Investors are throwing serious cash, think billions, at companies using artificial intelligence to shake up the pharmaceutical industry. Over the past decade, a jaw-dropping USD 60 billion has flooded into AI healthcare startups, with USD 30 billion of that in just the last [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":32432,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[2880,22330,22339,22538,18113,22517,22286,1837,2385,20471,20473,21202,20689,22503,19288,10106,137,22549,2753,17021,16975],"industry":[17226],"therapeutic_areas":[17242,17239,17231,17245,17228,17243],"class_list":["post-32430","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-ai","tag-ai-in-cancer-diagnostics","tag-ai-in-cybersecurity","tag-ai-in-diagnostics","tag-ai-in-healthcare","tag-ai-in-mental-health","tag-ai-in-respiratory-care","tag-artificial-intelligence","tag-artificial-intelligence-ai","tag-artificial-intelligence-ai-in-drug-commercialization","tag-artificial-intelligence-ai-in-drug-discovery","tag-artificial-intelligence-application","tag-artificial-intelligence-apps","tag-artificial-intelligence-diagnostics","tag-artificial-intelligence-in-drug-discovery","tag-artificial-intelligence-in-healthcare","tag-cancer","tag-generative-ai-in-drug-discovery","tag-medical-device","tag-medical-devices-market","tag-medtech-market","industry-medical-devices","therapeutic_areas-cardiovascular-diseases","therapeutic_areas-gastroenterology","therapeutic_areas-infectious-diseases","therapeutic_areas-neurology","therapeutic_areas-oncology","therapeutic_areas-respiratory-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AI Healthcare Startups: Investment &amp; Funding Trends<\/title>\n<meta name=\"description\" content=\"Discover how AI healthcare startups are attracting billions in funding and reshaping the future of healthcare and pharma.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AI Healthcare Startups: Investment &amp; Funding Trends\" \/>\n<meta property=\"og:description\" content=\"Discover how AI healthcare startups are attracting billions in funding and reshaping the future of healthcare and pharma.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-11T12:22:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-09T12:03:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174928\/Feature-AI-Healthcare-Startups_-Unveiling-Investment-and-Funding-Trends.png\" \/>\n\t<meta property=\"og:image:width\" content=\"466\" \/>\n\t<meta property=\"og:image:height\" content=\"284\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jatin Vimal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jatin Vimal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AI Healthcare Startups: Investment & Funding Trends","description":"Discover how AI healthcare startups are attracting billions in funding and reshaping the future of healthcare and pharma.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends","og_locale":"en_US","og_type":"article","og_title":"AI Healthcare Startups: Investment & Funding Trends","og_description":"Discover how AI healthcare startups are attracting billions in funding and reshaping the future of healthcare and pharma.","og_url":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2025-06-11T12:22:42+00:00","article_modified_time":"2025-10-09T12:03:59+00:00","og_image":[{"width":466,"height":284,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174928\/Feature-AI-Healthcare-Startups_-Unveiling-Investment-and-Funding-Trends.png","type":"image\/png"}],"author":"Jatin Vimal","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Jatin Vimal","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","FAQPage"],"@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends","url":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends","name":"AI Healthcare Startups: Investment & Funding Trends","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174928\/Feature-AI-Healthcare-Startups_-Unveiling-Investment-and-Funding-Trends.png","datePublished":"2025-06-11T12:22:42+00:00","dateModified":"2025-10-09T12:03:59+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158"},"description":"Discover how AI healthcare startups are attracting billions in funding and reshaping the future of healthcare and pharma.","mainEntity":[{"@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011408292"},{"@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011416073"},{"@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011427004"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174928\/Feature-AI-Healthcare-Startups_-Unveiling-Investment-and-Funding-Trends.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174928\/Feature-AI-Healthcare-Startups_-Unveiling-Investment-and-Funding-Trends.png","width":466,"height":284,"caption":"ai-healthcare-startups-funding-trends"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158","name":"Jatin Vimal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","caption":"Jatin Vimal"},"sameAs":["https:\/\/www.delveinsight.com"]},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011408292","position":1,"url":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011408292","name":"What is the overall scale of funding into AI healthcare startups?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Over the past decade, AI healthcare startups have attracted about USD 60 billion in funding, with USD 30 billion of that raised in the last three years. In 2024 alone, these startups raised USD 10.5 billion across 511 deals.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011416073","position":2,"url":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011416073","name":"Which promising AI healthcare startups are making waves?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Several startups are making waves, including Xaira Therapeutics, Intrepid Labs, Aeon, Kiin Bio, OpenEvidence, Axxam &amp; Molecular Health, and others.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011427004","position":3,"url":"https:\/\/www.delveinsight.com\/blog\/ai-healthcare-startups-funding-trends#faq-question-1760011427004","name":"What are the primary applications driving investment in AI healthcare startups?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Key areas attracting investment include Drug Discovery, Diagnostics, Clinical Decision Support, and others.","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"author_meta":{"display_name":"Jatin Vimal","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/jatin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/06\/11174928\/Feature-AI-Healthcare-Startups_-Unveiling-Investment-and-Funding-Trends-300x183.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">AI<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">AI in Cancer Diagnostics<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">AI in cybersecurity<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">AI in Diagnostics<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">AI In Healthcare<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">AI in Mental Health<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">AI in Respiratory Care<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">artificial intelligence<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">artificial intelligence (AI)<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Artificial Intelligence (AI) In Drug Commercialization<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Artificial Intelligence (AI) In Drug Discovery<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Artificial Intelligence Application<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Artificial Intelligence Apps<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">artificial intelligence diagnostics<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Artificial Intelligence in Drug Discovery<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Artificial intelligence in healthcare<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Generative AI in Drug Discovery<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">medical device<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Medical Devices Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">MedTech Market<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">AI<\/span>","<span class=\"advgb-post-tax-term\">AI in Cancer Diagnostics<\/span>","<span class=\"advgb-post-tax-term\">AI in cybersecurity<\/span>","<span class=\"advgb-post-tax-term\">AI in Diagnostics<\/span>","<span class=\"advgb-post-tax-term\">AI In Healthcare<\/span>","<span class=\"advgb-post-tax-term\">AI in Mental Health<\/span>","<span class=\"advgb-post-tax-term\">AI in Respiratory Care<\/span>","<span class=\"advgb-post-tax-term\">artificial intelligence<\/span>","<span class=\"advgb-post-tax-term\">artificial intelligence (AI)<\/span>","<span class=\"advgb-post-tax-term\">Artificial Intelligence (AI) In Drug Commercialization<\/span>","<span class=\"advgb-post-tax-term\">Artificial Intelligence (AI) In Drug Discovery<\/span>","<span class=\"advgb-post-tax-term\">Artificial Intelligence Application<\/span>","<span class=\"advgb-post-tax-term\">Artificial Intelligence Apps<\/span>","<span class=\"advgb-post-tax-term\">artificial intelligence diagnostics<\/span>","<span class=\"advgb-post-tax-term\">Artificial Intelligence in Drug Discovery<\/span>","<span class=\"advgb-post-tax-term\">Artificial intelligence in healthcare<\/span>","<span class=\"advgb-post-tax-term\">Cancer<\/span>","<span class=\"advgb-post-tax-term\">Generative AI in Drug Discovery<\/span>","<span class=\"advgb-post-tax-term\">medical device<\/span>","<span class=\"advgb-post-tax-term\">Medical Devices Market<\/span>","<span class=\"advgb-post-tax-term\">MedTech Market<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 1 year ago","modified":"Updated 8 months ago"},"absolute_dates":{"created":"Posted on Jun 11, 2025","modified":"Updated on Oct 9, 2025"},"absolute_dates_time":{"created":"Posted on Jun 11, 2025 5:52 pm","modified":"Updated on Oct 9, 2025 5:33 pm"},"featured_img_caption":"ai-healthcare-startups-funding-trends\n\n","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/32430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=32430"}],"version-history":[{"count":3,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/32430\/revisions"}],"predecessor-version":[{"id":33662,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/32430\/revisions\/33662"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/32432"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=32430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=32430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=32430"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=32430"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=32430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}